More intensive chemotherapy dramatically improves recurrence, survival in younger patients with aggressive lymphoma
Younger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive significantly longer, and are approximately twice as likely to remain in remission 3 years ...
Cancer
Nov 24, 2011 |
not rated yet |
0
Gene responsible for relapses in young leukemia patients
One of the causes of resistance to cancer treatment in children is now beginning to be elucidated. Acute lymphoblastic leukemia patients with a particular form of the ATF5 gene are at higher risk of having a relapse when ...
Cancer
Oct 26, 2011 |
not rated yet |
0
Compound found in common wart treatment shows promise as leukemia therapy
A new potential leukemia therapy targets only cancer cells, while leaving healthy cells alone. Many current chemotherapy treatments affect cancer cells and healthy cells, causing significant side effects, such as fatigue, ...
Cancer
Oct 26, 2011 |
not rated yet |
1
Pediatric cancer and palliative care: parental preferences compared with health-care professionals
Parents of children in the palliative stage of cancer favour aggressive chemotherapy over supportive care compared with health care professionals, states an article in CMAJ (Canadian Medical Association Journal).
Health
Oct 17, 2011 |
not rated yet |
0
Study finds that less is more for common cancer drug
University of Georgia scientists have found that smaller, less toxic amounts of chemotherapy medicine given frequently to mice with human prostate cancer noticeably slowed tumor growth. The mice suffered fewer ...
Cancer
Sep 30, 2011 |
4 / 5 (1) |
0
Chemo plus radiation before surgery increases tumor response for rectal cancer
Rectal cancer patients who use a new combination of the chemotherapy, Capecitabine, together with five weeks of radiation (50 Gy) before surgery have an 88 percent chance of surviving the cancer three years after treatment, ...
Cancer
Sep 26, 2011 |
not rated yet |
0
Fish oil reduces effectiveness of chemotherapy
Researchers at University Medical Center Utrecht, the Netherlands, have discovered a substance that has an adverse effect on nearly all types of chemotherapy - making cancer cells insensitive to the treatment. Chemotherapy ...
Cancer
Sep 12, 2011 |
5 / 5 (2) |
0
Gene therapy kills breast cancer stem cells, boosts chemotherapy
Gene therapy delivered directly to a particularly stubborn type of breast cancer cell causes the cells to self-destruct, lowers chance of recurrence and helps increase the effectiveness of some types of chemotherapy, researchers ...
Cancer
Sep 12, 2011 |
5 / 5 (2) |
0
|
Concurrent chemo and radiation therepy improves long-term survival for inoperable stage III lung cancer
Nearly 50,000 Americans are diagnosed each year with stage III or locally advanced NSCLC, for which surgery is usually not a viable treatment option. Optimizing nonsurgical treatment strategies for these patients is an ongoing ...
Cancer
Sep 08, 2011 |
not rated yet |
0
Chemotherapy is as effective before breast cancer surgery as after
Whether chemotherapy is given before or after breast-conserving therapy (BCT) does not have an impact on long-term local-regional outcomes, suggesting treatment success is due more to biologic factors than chemotherapy timing, ...
Cancer
Sep 08, 2011 |
not rated yet |
0
|
Choice of seizure drug for brain tumor patients may affect survival
New research suggests brain tumor patients who take the seizure drug valproic acid on top of standard treatment may live longer than people who take other kinds of epilepsy medications to control seizures. The research is ...
Neuroscience
Aug 31, 2011 |
not rated yet |
0
Targeting a cure: Research looks at developing a bull's-eye therapy to combat lung cancer
A Kansas State University professor is trying to create a patient-friendly treatment to help the more than 220,000 people who are diagnosed with lung cancer each year.
Cancer
Aug 22, 2011 |
not rated yet |
0
|
17 percent of cancer nurses unintentionally exposed to chemotherapy, study finds
Nearly 17 percent of nurses who work in outpatient chemotherapy infusion centers reported being exposed on their skin or eyes to the toxic drugs they deliver, according to a new study from the University of Michigan Comprehensive ...
Cancer
Aug 22, 2011 |
not rated yet |
0
Olaparib shows promise in treating ovarian cancer, even without BRCA mutations
The PARP inhibitor, olaparib, that has shown promise in women with an inherited mutation in their BRCA1 or BRCA2 gene (accounting for about 5-10% of breast and ovarian cancer cases), has, for the first time, been shown to ...
Cancer
Aug 21, 2011 |
not rated yet |
0
|
Survival of stage IV breast cancer patients improves with stem cell treatment, study finds
(Medical Xpress) -- A new long-term study of women with Stage IV breast cancer at the Stanford University School of Medicine is likely to revive a decade-old debate about high-dose chemotherapy as a treatment option. Specifically, ...
Cancer
Jul 25, 2011 |
not rated yet |
0
|
